CMC welcomes the recent announcement from the MHRA relating to CBMPs

The Centre for Medicinal Cannabis welcomes the recent announcement from the Medicines and Healthcare products Regulatory Agency (MHRA) regarding the process for approving manufacturing authorisations or API registrations of Cannabis Based Medicinal Products (CBMPs). The piece outlines the MHRA and Home Office licensing requirements for companies and facilities operating within the UK, and provides clarity …

CMC co-launches in-depth review of the UK’s cannabinoid industry with 20 key recommendations

CMC co-launches in-depth review of the UK’s cannabinoid industry with 20 key recommendations In February this year following a series of meetings with Ministers, advisers and senior officials in Whitehall the Centre of Medicinal Cannabis and the Association for the Cannabinoid Industry commissioned Oxford University’s Professor Christopher Hodges to oversee a comprehensive review of the …

CMC welcomes Dr Elisabeth Philipps as our new Clinical Advisor

The Centre for Medicinal Cannabis is delighted to announce that Dr Elisabeth Philipps has joined our growing team of esteemed medical experts as our Clinical Advisor. Dr Elisabeth is a clinical neuroscientist and integrative medicine practitioner who founded a consultancy specialising in brain health, the endocannabinoid system and phytocannabinoids including CBD and medicinal cannabis. She …

[Press release] UK Medicinal Cannabis Industry Calls for Bold New Policies to Increase Patient Access and Clinical Understanding of Medicinal Cannabis

UK Medicinal Cannabis Industry Calls for Bold New Policies to Increase Patient Access and Clinical Understanding of Medicinal Cannabis The UK’s industry leadership body, the Centre for Medicinal Cannabis, today launches a report calling on the government to adopt novel, bolder approaches to policy making in relation to medicinal cannabis. Three years after medicinal cannabis was …